Sofinnova Partners is a leading European venture capital firm specializing in life sciences, healthcare, and sustainability. Founded in 1972 and headquartered in Paris, it acts as a hands-on company builder across the entire value chain of life sciences investments, from incubation through later-stage growth.
47% of their portfolio is in Biotech & Life Sciences. Deal activity increased 33% year-over-year (28 deals in the last 12 months). Average disclosed round size is $68.9M (across 262 rounds with reported amounts).
Portfolio
259
Fund Size
$750M
Top Stage
Series A
Last 12 Mo
28
Team
David Evans
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
430 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Aiolos | Series A | $245M | Sep 2026 |
 Mironid | Series B | $46M | Aug 2026 |
 City Therapeutics | Series B | $99.5M | Jun 2026 |
| IIngenix | Seed | — | Jun 2026 |
| PP2 Science Inc. | Unknown | $23M | May 2026 |
 Coultreon Biopharma | Series A | $125M | Apr 2026 |
 Coultreon Biopharma | Series A | $125M | Apr 2026 |
 Verley | Series A | — | Feb 2026 |
 Verley | Series A | — | Feb 2026 |
 Neurent Medical | Series C | $74M | Feb 2026 |
 Tenpoint Therapeutics | Series B | — | Jan 2026 |
 BrightHeart | Series A | — | Jan 2026 |
 Mediar | Series B | $76M | Jan 2026 |
| CClaris Bio | Series B | $57M | Jan 2026 |
| NNanoPhoria | Series A | — | Jan 2026 |
| Coultreon Biopharma | Series A | $125M | Jan 2026 |
| Coultreon Biopharma | Series A | $125M | Jan 2026 |
| IIngenix | Seed | — | Jan 2026 |
 Claris | Series B | $118M | Jan 2026 |
 Artios | Series D | $115M | Nov 2025 |
 myTomorrows | Growth | $29M | Nov 2025 |
 AAVantgarde Bio | Series B | — | Nov 2025 |
| HHemab | Series C | $157M | Oct 2025 |
 Elevara Medicines | Series A | $70M | Oct 2025 |
 Mission Therapeutics | Unknown | $13.3M | Oct 2025 |
Page 1 of 18
Top Co-Investors
Forbion42 shared
Novo Capital30 shared
Bpifrance30 shared
OrbiMed29 shared
Pfizer Ventures28 shared
Novo Holdings A/S25 shared
Cormorant Asset Management25 shared
Alexandria Venture Investments23 shared
The Invus Group, LLC23 shared
RA Capital Management22 shared
Atlas Venture19 shared
M Ventures19 shared
Surveyor Capital18 shared
T. Rowe Price18 shared
EQT Life Sciences17 shared
New Enterprise Associates17 shared
F-Prime Capital16 shared
GG116 shared
Rock Springs Capital16 shared
Andera Partners16 shared
Last updated: 7 October 2026